
ACADIA Pharmaceuticals ACAD
$ 22.2
-2.07%
Annual report 2024
added 02-27-2025
ACADIA Pharmaceuticals Depreciation & Amortization 2011-2026 | ACAD
Annual Depreciation & Amortization ACADIA Pharmaceuticals
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 920 K | 1.46 M | 2.03 M | 2.24 M | 1.46 M | 1.29 M | 1.53 M | 1.24 M | 843 K | 647 K | 206 K | 79 K | 109 K | 285 K |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 2.24 M | 79 K | 1.02 M |
Quarterly Depreciation & Amortization ACADIA Pharmaceuticals
| 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 426 K | - | - | 1.03 M | 516 K | - | 400 K | 1.08 M | 525 K | - | 986 K | 648 K | 294 K | - | 1.02 M | 741 K | 415 K | - | 1.12 M | 734 K | 392 K | - | 904 K | 577 K | 270 K | - | 583 K | 342 K | 138 K | - | 519 K | 402 K | 122 K | - | 145 K | 85 K | 43 K | - | 40 K | 24 K | 12 K | - | 88 K | - | 30 K | - | 255 K | 225 K | 189 K |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 1.12 M | 12 K | 438 K |
Depreciation & Amortization of other stocks in the Biotechnology industry
| Issuer | Depreciation & Amortization | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Applied Genetic Technologies Corporation
AGTC
|
1.51 M | - | - | $ 26.5 M | ||
|
Allakos
ALLK
|
6.14 M | - | - | $ 28.6 M | ||
|
Advaxis
ADXS
|
369 K | - | -9.65 % | $ 45.9 M | ||
|
Akouos
AKUS
|
2.49 M | - | 0.23 % | $ 488 M | ||
|
AlloVir
ALVR
|
13 K | - | 4.14 % | $ 49.1 M | ||
|
I-Mab
IMAB
|
23.9 M | - | - | $ 866 M | ||
|
Aeglea BioTherapeutics
AGLE
|
744 K | - | - | $ 1.01 B | ||
|
Ampio Pharmaceuticals
AMPE
|
122 K | - | -11.43 % | $ 502 K | ||
|
Aptorum Group Limited
APM
|
1.13 M | $ 0.89 | 1.48 % | $ 6.54 M | ||
|
Applied Molecular Transport
AMTI
|
3.13 M | - | - | $ 10.1 M | ||
|
AIkido Pharma
AIKI
|
105 K | - | 1.93 % | $ 17.4 M | ||
|
Aptinyx
APTX
|
122 K | - | -39.0 % | $ 4.57 M | ||
|
ImmuCell Corporation
ICCC
|
2.78 M | $ 8.44 | 1.08 % | $ 76.2 M | ||
|
Innoviva
INVA
|
26.3 M | $ 23.05 | -2.7 % | $ 1.55 B | ||
|
Jaguar Health
JAGX
|
1.91 M | $ 0.23 | -6.64 % | $ 536 K | ||
|
Aeterna Zentaris
AEZS
|
58 K | - | 5.93 % | $ 314 M | ||
|
Ayala Pharmaceuticals
AYLA
|
162 K | - | - | $ 7.46 M | ||
|
AgeX Therapeutics
AGE
|
100 K | - | -10.17 % | $ 12.2 K | ||
|
Aravive
ARAV
|
886 K | - | -13.39 % | $ 1.45 M | ||
|
Aridis Pharmaceuticals
ARDS
|
487 K | - | 17.91 % | $ 11.1 M | ||
|
Atreca
BCEL
|
5.46 M | - | -11.76 % | $ 5.79 M | ||
|
Brainstorm Cell Therapeutics
BCLI
|
199 K | - | -2.5 % | $ 5.88 M | ||
|
BioDelivery Sciences International
BDSI
|
140 K | - | -4.8 % | $ 255 M | ||
|
Aquestive Therapeutics
AQST
|
548 K | $ 4.05 | -0.98 % | $ 433 M | ||
|
Arcutis Biotherapeutics
ARQT
|
700 K | $ 22.37 | -3.95 % | $ 2.85 B | ||
|
Autolus Therapeutics plc
AUTL
|
8.3 M | $ 1.41 | -4.73 % | $ 375 M | ||
|
Aptose Biosciences
APTO
|
22 K | - | -45.71 % | $ 1.2 M | ||
|
AVROBIO
AVRO
|
617 K | - | 1083.1 % | $ 745 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
24 K | $ 2.98 | 2.41 % | $ 4.91 M | ||
|
Madrigal Pharmaceuticals
MDGL
|
1.51 M | $ 518.58 | 0.37 % | $ 11.6 B | ||
|
BeiGene, Ltd.
BGNE
|
142 M | - | 0.49 % | $ 251 B | ||
|
Akero Therapeutics
AKRO
|
18 K | - | - | $ 3.67 B |